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Introduction 
 
Parkinson's disease (PD) is one of the long-term conditions largely affecting the older 
population, currently diagnosed when the part of the brain that controls movement is affected 
by a deficiency of a neurotransmitter dopamine (motor symptoms), but also evident from the 
presence of non-motor symptoms such as depression, fatigue and pain that manifest before 
the motor features (Schrag et al. 2014). There is no cure for Parkinson’s, but early diagnosis 
can help in enabling the person to self-manage their condition through support from health 
professionals, carers and families (Baker and Graham, 2004).  
There are an estimated 127,000 people living with Parkinson’s in the UK (Parkinson’s UK, 
2015), and even this figure is considered a great underestimation. The provision of both 
health and social care services to address the management of Parkinson’s, especially as the 
condition progresses and as the person ages, has the potential to generate a large economic 
and financial cost to the individual, to the Government and society. However, there is a lack 
of research in estimating this total cost in the UK.  
As Parkinson’s is progressive, with both motor- and non-motor symptoms developing at 
varied times over the course to the condition requiring different strategies and inputs, the 
estimated cost for management is large, with a likely substantial imposition on quality of life. 
Much of Parkinson’s care is informal, meaning that the impact on quality of life is not 
restricted to the individual with Parkinson’s, but extends to carers, family, and friends 
(Williamson et al. 2008).  
Given the large, and increasing numbers of people with Parkinson’s in the UK, it would be of 
benefit to understand the cost of care, management and effective treatment available in the 
UK to the individual with Parkinson’s and to society. 
The literature review aimed to gather evidence on the impact of Parkinson’s on the socio-
economic life of individuals with the condition, their families and society based on prior 
research undertaken in the UK. The review also sought to enable a better understanding of the 
key medical and non-medical cost components directly associated with Parkinson's 
management and care, with an understanding of where public resources are currently directed. 
The literature has been synthesised using a comprehensive and transparent literature review 
process 
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1.  Methods  
Inclusion criteria: The review searched for published, peer-reviewed papers and grey 
literature from the UK, which underpins and quantify the direct and indirect impact of 
Parkinson's on society. Articles published in the English language between 1991 and 2015 
were eligible for inclusion. All quantitative and/or qualitative study types were included.  
Search strategy: The literature search strategy was developed in consultation with the 
research team and comprised three facets: (1) terms for Parkinson's, (2) terms to describe the 
costs associated with the condition, such as financial, employment, pension, housing, 
healthcare costs, quality of life (QoL), and (3) terms to limit to studies situated in the UK.  
All terms were searched for in the title and abstract fields and controlled vocabulary terms 
used where available. The Boolean operators AND and OR were used, alongside truncation, 
phrase searching and proximity operators. The following databases were searched: ASSIA 
(ProQuest), CINAHL (EBSCO), Cochrane Library (Wiley), EMBASE (via National Health 
Service Healthcare databases), MEDLINE (EBSCO) and Web of Science (Thomson Reuters). 
All search results were exported to RefWorks, a bibliographic management tool. A copy of 
the search strategy is provided in Appendix 1.  
Quality appraisal and study selection: After removal of most duplicate records, the database 
searches retrieved 2143 papers. In the first instance, the titles of all retrieved papers were 
screened for relevancy, with abstracts read where necessary. This resulted in a shortlist of 79 
papers. A second, thorough screening of the abstracts and full text of all shortlisted papers 
resulted in 50 papers deemed relevant to this review. The 29 papers excluded at this stage 
were eliminated for the following reasons: six were duplicates, two were descriptive in nature, 
seven were conference abstracts, nine were non-UK based studies, two were 
letter/advocacy/media papers, and three focused on validating scales/questionnaires. The 
scrutinising and selection of papers for inclusion were carried out by two members of the 
research team. The literature search screening process is summarised in the flow chart 
(adapted from Moher et al., The PRISMA Group, 2009) in Figure 1.  
Data extraction and synthesis: Papers meeting the inclusion criteria were read and data 
extracted using a standardised extraction form encompassing: author ⁄ date, the focus of the 
study, research design and sample size. The evidence was grouped into five themes: (a) 
Parkinson's incidence differentials by socio-economic status, (b) Parkinson's management 
and care, (c) Impact on QoL and wellbeing of PwP, carers and family members, (d) Cost of 
healthcare use, and (e) Societal cost of Parkinson’s. 
  
3 
 
Figure 1: Search one: flow chart of the literature review selection process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Studies Included for Review 
Final inclusion of papers: A majority of the papers included in the literature review studied 
the impact on quality of life of PwP, carers and their family members (27 papers). Out of 
these, 10 papers examined the impact on the health and wellbeing of the caregivers (in the 
majority of cases, the papers focused on spouses) and other family members. A small number 
of studies (12) focused on estimating the healthcare costs of Parkinson’s, costs to the families 
of PwP as well as on society. A brief summary of the topics covered by these studies as well 
as their detailed references are presented in Tables 2 to 5. 
Grey Literature Search: Grey literature searches were undertaken on NICE Evidence Search 
and Google. Grey literature was considered essential to this research and its inclusion is 
aligned to the comprehensive review methodology, as previously outlined. The inclusion of 
grey literature also helped minimise publication bias (Booth, Papaioannou and Sutton 2012: 
p.77). The grey literature searches used an abridged set of search terms; this was due to NICE 
Evidence Search and Google allowing a limited number of characters. The most salient 
search terms were identified through a scan of the literature yielded from the database 
searches. Most identified grey literature studies have already got published and thus 
duplicated with our previous searches. After screening for direct relevancy to costs of 
Papers screened by title (and abstract were 
necessary) 
(n = 2143) 
Papers identified through database searching  
(n = 3046) 
Papers after duplicates removed  
(n = 2143) 
Abstract and full-text papers screened for 
eligibility (n = 79) 
Papers included in this review  
(n = 50) 
Papers excluded  
(n = 29) 
Papers excluded due to following 
reasons: 
six duplicates, two descriptive in 
nature, seven conference 
abstracts, nine non-UK based 
studies, two letter/advocacy 
papers, three focused on 
validating scales/questionnaires  
Papers excluded  
(n = 2065) 
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Parkinson's, the grey literature searches yielded 8 additional resources which merit attention.  
The key findings from these resources are summarised below (Table 1). 
Table 1: Summary of key messages from grey literature studies  
1. To detect and serve: DaTSCAN SPECT used to diagnose in cases of uncertainty. Although this 
approach is costly, it can differentiate a dopaminergic deficit in non-Parkinsonian condition. 
The tools were benefits to the unnecessary treatment particularly anti-Parkinsonian drugs in 
people with no dopaminergic deficiency states and peoples 'quality of life. 
2. Protect Parkinson’s nurses in England and save the NHS money: Parkinson’s nurses had played 
a significant role in care and help of PwP. Their timely visit and intervention influenced to 
reduce in avoiding unnecessary consultant appointment, unplanned admission, re-admission, 
and length of stay in the hospital, thereby saving an additional NHS expenditure of £35.1 
million per year. However, there was currently the budget constraint, as a result, Parkinson’s 
nurse service may be decreased in the investment. It meant that PwP were likely to omit 
delivering vital care from Parkinson’s nurses affecting on Parkinson’s themselves and their 
carers. 
3. Royal College of Nursing (RCN) Factsheet: Specialist nursing in the UK: Specialist nurses were 
significant for patients. They provided tailored care for individual. The Parkinson’s nurse can 
potentially save unnecessary costs in healthcare system of almost £148,000 per year in bed days, 
£44,000 for avoiding consultant appointments, and £80,000 for unplanned admission. 
4. Medical experts call for hospitals to ensure Parkinson’s patients get the right treatment after 
report reveals they are twice as likely to die compared to other people following A&E 
admission: PwP were more likely to be admitted as an emergency admission than for planned 
medical procedures (72% v. 28% respectively). Emergency admissions for PwP costed the NHS 
annually £200m (£3,338 per PwP as compared to £1,417 for a planned nonemergency hospital 
stay). The main causes for emergency admissions were pneumonia, physical deterioration, 
urinary tract infection and hip fractures, and PwP were up to twice as likely to be admitted for 
these conditions compared to the average patient. Further, PwP were almost twice as likely to 
stay in the hospital for more than 3 months and almost 2.5 times more likely to die in the 
hospital after an A&E admission. There is an urgency to ensure that PwP receive the correct, 
cost-effective interventions to reduce the burden of unplanned hospital admissions. 
5. England hospital Episode Statistics Project: The results from a cross-sectional analysis of 
England hospital database for 2009-2013 showed 324,055 hospital admissions by 182,859 PwP 
with the larger figure for non-elective than elective admissions. The share of emergency 
admission was 72% (costing £777 million). The main unplanned admissions were for 
pneumonia, motor deterioration, urinary tract infection, and hip fractures.  PwP was more likely 
to stay longer (up to 7 days) at the hospital than their controls; there was also a two-fold share of 
PwP compared to controls for admission having a length of hospital stay exceeding more than 3 
months. Therefore, people affected by Parkinson’s should receive an accurate diagnosis of 
condition to get timely treatment. 
6. Parkinson’s Fact Sheet: The number of PwP was approximately 120,000 in the UK in 2011.  
The manifestation of Parkinson’s shows in three main symptoms, including bradykinesia, 
tremor and rigidity; a diagnosis of Parkinson’s is based on having bradykinesia and one or two 
of the other three symptoms. An autopsy is an absolute approach for the diagnosis of 
Parkinson’s. However, there are tools to help differential states namely PET scan, DaTSCAN, 
and CT and MRI. Parkinson’s has a significant impact on quality of life of both PwP and their 
carers. This disorder directly affects ability to work thus forcing many PwP to withdraw from 
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their jobs and occupation. There is also a tendency to a reduction in working hours for carers. 
PwPs are also likely to become isolated. The effect of Parkinson’s on the socio-economic 
burden, therefore, affects both the PwP and carers. 
7. Life with Parkinson’s Non-motor symptoms: Parkinson’s has an economic impact on both direct 
and indirect costs. The direct costs are presented in terms of medicine and medical care; the 
indirect costs are associated with loss of employment in person with the disease and also some 
carers. The major problem occurring in people with Parkinson’s is non-motor symptoms that 
these are not related to the movement difficulty in Parkinson’s. 
8. Parkinson’s Change Attitudes: The PwP needed assistance for their daily living for instance 
support from someone (42.8% of PwP), transport (42.8%), motability (40.9%), health treatment 
(25.9%), and mobility aid (22.0%) and thus resulted in extra money spent per month.  
References  
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3. Main Findings from Studies 
3.1 Incidence of Parkinson’s by Socioeconomic Status and Geography 
Using Primary Care practices data in North East Scotland, Caslake et al. (2013) estimated the 
crude annual incidence of Parkinson’s at 28.7 per 100,000 persons with a higher incidence in 
men (21.1) compared to women (14.7). The incidence of Parkinson’s has risen exponentially 
with age particularly post 60 years in both men and women (incidence increased from 11.9 in 
50-59 years to 149.3 in 80-89 age group). The overall age-adjusted male- female ratio for 
Parkinson’s incidence was 2.18. However, the incidence didn't significantly vary by level of 
deprivation in Scotland. Caslake et al. (2013) also undertook a meta-analysis of 12 similar 
international studies (of which three were UK based). In other UK studies, the estimated 
Parkinson’s incidence which varied between 13.3 and 18.3 was lower than estimated by 
Caslake et al. study for North East Scotland.    Dick et al. (2007) epidemiological study 
(conducted in four European countries: northern Scotland, south-eastern Sweden, northern 
Italy and eastern Romania) examined the association between occupational exposure and 
incidence of Parkinson’s. Scottish data showed a non-significant increased risk for agriculture 
but significantly reduced the risk for ‘transport and communication’ for developing 
Parkinson’s incidence. However, overall there was no significant relationship between 
lifetime toxic occupations exposure and incidence of developing Parkinson’s. 
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Horsfall et al. (2013) examined time trends and the influence of socio-demographic and 
geographic factors on the incidence of Parkinson’s diagnosis using UK Primary Care 
database for patients aged over 50 years. The incidence of Parkinson’s varied by age, gender, 
time period, social deprivation score and urban/rural status. The overall incidence of 
Parkinson’s for people over 50 years was 84 per 100,000 person years. After accounting for 
socio-demographic factors, the adjusted incidence rates were 46 % higher in men than in 
women, 12% higher in urban than rural areas and marginally lower in less socially deprived 
areas. Over time, there was a downward trend in Parkinson’s diagnosis with the adjusted 
incidence rate declining by around 6% every calendar year between 1999 and 2009 which 
may largely represent changes in diagnosis and/or coding rather than a true decline in 
incidence. The study concluded that the Parkinson’s diagnosis rates in the primary care 
setting were higher in men and greater in urban areas but not different between socio-
economic groups.  
 
Table 2: UK Studies on Parkinson’s incidence differentials by socio-economic status 
 Theme and Focus Design / Sample Size Reference 
1. Socio-economic status (SES) 
and deprivation (Scotland) 
Epidemiological: 377 PwP, meta-
analysis 
CASLAKE et al. 
(2013) 
2. SES and occupational exposure 
Epidemiological: 649 exposed and 
1587 controls 
DICK et al. 
(2007) 
3. SES and deprivation  
Longitudinal: aged 50+ from 469 
GP sites. Incidence rates using 
two case definitions: Broad (6,813 
men and 5,929 female), Narrow 
(5,207 men, 3,844 female) 
HORSFALL et 
al. (2013) 
References 
CASLAKE, R., TAYLOR, K., SCOTT, N., GORDON, J., HARRIS, C., WILDE, K., MURRAY, A. and COUNSELL, C., 
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Scotland: The PINE study. Parkinsonism and Related Disorders, 19(5), pp. 515-521.  
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Occupational Medicine-Oxford, 57(1), pp. 50-56.  
 
HORSFALL, L., PETERSEN, I., WALTERS, K. and SCHRAG, A., 2013. Time trends in incidence of Parkinson's disease 
diagnosis in UK primary care. Journal of neurology, 260(5), pp. 1351-1357.  
 
3.2  Parkinson’s Management and Care 
Deane et al. (2014) undertook a study with stakeholders (PwP, caregivers, family and friends 
of PwP, healthcare and social care professionals) to identify and prioritise the top 10 
evidential uncertainties that impact on everyday clinical practice for the management of 
Parkinson’s in the UK. After surveying 1000 participants and in-depth discussions, 
stakeholders agreed on the following top 10 research priorities for Parkinson’s management: 
the need to address motor symptoms (balance and falls, and fine motor control), non-motor 
symptoms (sleep and urinary dysfunction), mental health issues (stress and anxiety, dementia 
and mild cognitive impairments), side effects of medications (dyskinesia) and the need to 
develop interventions specific to the phenotypes of Parkinson’s and better monitoring 
methods.  Deane et al. study thus identified crucial gaps in the existing evidence to address 
everyday practicalities in the management of the complexities of Parkinson’s. 
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Skelly et al. (2015) studied views of consultant geriatricians and neurologists and PDNS on 
the quality of in-hospital care provided to PwP. The study found wide variations in the 
standard of care and one-fifth of hospital professionals rated overall standard of care as poor 
and three-fifths felt that medications were not given on time. The study suggested piloting 
various interventions to improve the care of PwP in hospitals. 
Walker et al (2011) study aimed to assess the PwP health and social care living in North 
Northumberland (mostly rural area), UK.  About 13.3% of PwP were living in institutional 
care, and remaining 86.7% living in their own homes. Those living at own homes 27.7% had 
domestic home care services provided and 26.2% used personal home care services. Five 
PwP had significant care input from a carer or family member (7.7%) and 11 from a care 
worker (17%). Two patients were regularly visited by a district nurse, one by a social worker, 
and four by an occupational therapist and two patients regularly attended a local day care 
centre. The study concluded that living in a rural area appeared to be no hindrance to 
accessing care services when they were required. 
Armitage et al. (2009) undertook in-depth interviews of PwP and their close relatives in care 
homes to explore the effectiveness of care specifically on the role of family members in 
implementing care pathway. Five primary themes included were:  lack of information about 
PwP, functional variation, nature of relatives’ involvement, care home environment and 
culture, and care provision. The study found an apparent shortfall in the knowledge and 
understanding of PwP among care home staff and there was a lack of involvement of PwP 
family in better management of care. 
McLaughlin et al. (2011) explored the caring experience of relatives of PwP for providing 
palliative care. All 26 caregivers were spouses, the majority female (n = 17) and all were 
responsible for providing physical, social and emotional care in the home. The majority 
(81%) were aged over 55 years of age and their caring ranged between two and over 20 years. 
Four themes emerged from the in-depth analysis: medical support for PwP, burden related to 
caregiving, information needs and economic implications.  Although they viewed caregiving 
as their role and duty, the results highlighted the widespread burden of providing care on the 
emotional and physical health of the caregivers. The financial implications for providing care 
were outlined, with many reporting difficulties in accessing benefits. From the point of 
diagnosis, which had a huge emotional impact on relatives and caregivers, many felt that 
health professionals hadn’t consulted them for the care pathway plan. Since diagnosis, 
caregivers commented on the lack of continued and coordinated care plans for relatives, 
resulting in symptoms being mismanaged and care opportunities for family and relatives 
missed. Stereotypes of the meaning and timing of palliative care were common with many 
viewing it as being synonymous with cancer and not applicable to a PwP. As the wellbeing of 
the informal caregiver directly influences the care of the PwP, support interventions are 
required to relieve their burden, maximise outcomes and ensure targeting of services. 
Waldron et al. (2013) examined the social worker's role in the delivery of palliative care to 
PwP. Differing perceptions of palliative care emerged: from a holistic approach to specialist 
care near the end of life. Negative associations of palliative care were identified. Other 
barriers also exist such as a lack of knowledge and experience of Parkinson’s and a lack of 
resources that hinder the delivery of palliative care to clients with chronic conditions. 
Different interpretations of palliative care affect its delivery to clients with LTC. Very few 
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PwP were referred to specialist palliative care specifically for management of their 
symptoms, which must prevent holistic care. Social workers have an important, yet 
underdeveloped, role in identifying and addressing palliative care needs. Participants stressed 
that palliative care provision should be extended to support family carers. They felt that the 
demanding role of a carer often goes unrecognised. Carers, who may have their own health 
problems, may have to adapt to their loss of independence, increased social isolation, 
physical exhaustion and psychological stress. They favoured a separate assessment of carers’ 
needs and respite provision for carers that would depend on factors such as clients’ level of 
mobility. Practical help, information, emotional support, referral to appropriate agencies that 
might be of benefit and respite opportunities were highlighted as carers’ needs. Policies and 
procedures should be clarified regarding prioritisation and access for clients with chronic 
LTC to appropriate palliative care.  
Higginson et al. (2012) examined changes in palliative care needs with Parkinson’s in late 
stage, shown by H&Y stage 3-5. Over two-thirds of patients had a severe disability, over one 
third being wheelchair-bound/bedridden. Over the year, half of the patients showed either an 
upward (worsening, 24/60) or fluctuant (8/60) trajectory on palliative care outcome scale and 
symptoms. The strongest predictors of higher levels of symptoms at the end of follow-up 
were initial scores on palliative care outcome scale and being male, both were more 
predictive than initial H&Y scores. The quality of life of PwP in late stage (measured through 
EuroQuol-5 dimension [EQ5D] and Parkinson’s Disease Quality of Life Questionnaire 
[PDQ]-8 tools) has deteriorated considerably over one year with one-thirds of PwP died. The 
findings point to profound and complex mix of non-motor and motor symptoms in PwP in 
late stage. Symptoms are not resolved and half of the patients deteriorate. Palliative problems 
are predictive of future symptoms, suggesting that an early palliative assessment might help 
screen for those in need of earlier intervention. 
The results have been summarised below (Table 3). 
Table 3: UK Studies on Parkinson’s management and care 
 Theme and Focus Design / Sample Size Reference 
1. Priority settings by clinicians, 
health professionals and families 
Cross-sectional: 1000 people DEANE et al. 
(2014) 
2. In-hospitalisation care: clinicians 
and health professionals view 
Cross-sectional: 93 staff SKELLY et al. 
(2015) 
3. Care services for rural PwP Cross-sectional: 75 PwP WALKER, 
SWEENEY and 
GRAY (2011) 
4. Effectiveness of care in nursing 
home 
Qualitative: carer's 
experience: 51 relatives and 
24 PwP 
ARMITAGE et al. 
(2009) 
5. Palliative care needs, QoL in 
Late stage 
Longitudinal: 82 PwP HIGGINSON et al. 
(2012) 
6. Palliative care needs, QoL of 
carers 
Qualitative:  26 carer's 
experience 
MCLAUGHLIN et 
al. (2011) 
7. Social workers' role Qualitative: 13 in-depth 
interviews of social workers 
WALDRON et al. 
(2013) 
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3.3 Quality of Life 
(A) Impact on quality of life and wellbeing of PwP 
Parkinson’s is a progressive condition and thus has a significant impact on QoL and 
wellbeing of PwP over time. A number of studies have documented the impact of the 
progression of Parkinson’s into the gradual loss of both motor and non-motor functions, 
consequently impacting on QoL of PwP. To recognise and factorize specific aspects of 
impact on QoL and wellbeing on PwP, the eighteen studies identified could be classified into 
two broad groups: First, Parkinson’s symptoms severity and diversity; second, self-help 
group and social support and their interface with health and wellbeing. 
1. Differential effects of symptoms with Parkinson’s stage  
Varied symptoms that emerge from the point of onset of Parkinson’s will worsen, particularly 
in people who have been diagnosed for more than 6 years (Politis et al. 2010). Both the 
experience of motor (movement) and non-motor symptoms directly affects the QoL of PwP 
from worry associated with further deterioration in QoL in PwP with condition progression. 
The Parkinson’s Disease Quality of Life Questionnaire (PDQ-39) which covered 8 domains 
and 39 items, is widely used as a disease-specific measure of health-related quality of life 
(HRQoL) in PwP. The eight domains included are: mobility, activities of daily living 
(ADLs), emotional wellbeing, stigma, social support, cognition, communication, and bodily 
discomfort.  
Motor symptoms: Bradykinesia, rigidity and tremor are the ‘cardinal motor symptoms’ 
affecting the everyday activities and life of PwP. Problematic mobility problems include 
shuffling gait, start hesitation, freezing, festination, propulsion, and difficulty in turning. The 
most importance consequence of the motor symptoms is falling, influencing costs related to 
injury, increased length of hospital stay, and restricting participation in social activities. 
Motor symptoms were also shown to significantly impact on QoL scores and thus resulted in 
poorer HRQoL in PwP (Rahman et al. 2008). In comparing the QoL of PwP attending 
movement disorders clinic vs. general medical clinic in Scotland, it was found that the QoL 
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of PwP attending the movement disorders clinic was significantly higher (Blackwell, Brown 
and Rochow, 2005). 
Non-motor symptoms: Non-motor symptoms manifest in a diverse range of symptoms 
comprising mood, cognition, sensory disturbance, autonomic disturbance, and pain. The level 
and degree of non-motor symptoms are correlated to advancing in age and severities of 
disease. The evidence suggests that these symptoms have a significantly greater influence on 
HRQoL of PwP from early through to the advanced stages of Parkinson’s. Depression, 
anxiety, impaired concentration, memory retrieval, sleep disturbance, and autonomic 
disturbance had shown significantly negative impacts on QoL (Findley et al. 2002; Politis et 
al. 2010; Rahman et al. 2008; Leroi et al. 2011; Duncan et al. 2014; Simpson, Lekwuwa and 
Crawford, 2014). Depression develops in approximately 50% of PwP as the condition 
progresses, and although the most troublesome of the non-motor symptoms, remains under-
recognised and lacking effective treatment (Politis et al. 2010).  
Shearer et al. (2012) evaluated health state utility value affecting motor and non-motor 
symptoms of patient with idiopathic Parkinson's using the EQ-5D. Findings indicated pain, 
depression, motor impairment and insomnia as the main declining factors in utility value of 
PwP. Depression had the greatest impact during the early stage of the condition. Thus an 
improvement of the main factors influencing utility value could contribute to an increase in 
QoL among PwP. 
In a survey of PwP, the most troublesome symptoms, pain was ranked the highest non-motor 
symptoms in an early Parkinson’s group, affecting the person enough to negatively affect 
QoL, in particular musculoskeletal and visceral pain (Politis et al. 2010). These symptoms 
resulted in a direct increase in medical and other health care cost, and should therefore be 
recognised as a key factor of this disorder, and taken into account for developing further 
optimal management. 
2. Self-help groups and social support in PwP 
As Parkinson’s progresses, literature highlighted three main alterations PwP encountered in 
their perception of experience living with Parkinson’s: change, addressing changes, and 
reflections on living with Parkinson’s (Benharoch and Wiseman 2004).  
First, the most common symptom changes in PwP included tremors, changes in movement 
quality, dribbling, difficulties in swallowing and speech, tiredness, problem in digestion, and 
deterioration of memory. Other changes included a decline in mobility, loss of employment, 
but gains in new skills due to being diagnosed with Parkinson’s. Second, the need to address 
changes identified medications management over time, reactions to other people’s 
involvement, occupations undertaken to maintain wellbeing, and finding new ways of doing 
things. Third, reflections on living with Parkinson have included thoughts on problems 
encountered, acceptance of the disease, self-consciousness, the importance of a positive 
attitude and maintaining normality. PwP who were participating in self-help groups were 
more likely to accept their condition and also adapt their usual lifestyle. However, they also 
expected that self-help groups should be more supportive. Conversely, PwP who were not 
supported socially reported higher scores/levels of distress, anxiety, stress, and less 
satisfaction (Simpson et al. 2006). Further, those PwP who had stronger social support in 
terms of number of close relationships had reported relatively much better psychological 
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outcomes (Simpson et al. 2006). Therefore, further research should be explored into social 
support and services that might mitigate deterioration in QoL of PwP.   
Barrow and Charlton (2002) explored how progression of the condition had affected the lives 
of eight PwP and whether self-help group membership was related to coping methods (four of 
the participants were members of the Parkinson's UK Society and four were not). It was 
found that all participants had experienced losses of physical and mental functioning and 
independence, self-identity and future and were afraid of further losses as the Parkinson’s 
progressed. Although all participants used a range of coping methods, it was found that there 
were differences between members and non-members in the prominence of certain methods 
and overall coping style. For non-members, coping centred upon maintaining a normal life 
and denying the condition a central role, but for group members, the condition and its likely 
consequences were accepted and incorporated into everyday life. The discourse of non-
members contained many references to a self-help group as a source of distress, while 
discourse of members identified it as a supportive resource. This exploratory study enhances 
our understanding of differences between people in their willingness to use a self-help group, 
and in turn, raises questions about the provision of psychological services in a chronic 
progressive disorder. 
To sum up, the QoL of PwP is mainly affected by non-motor and motor symptoms. Non-
motor symptoms include psychological wellbeing, particularly depression and anxiety. 
Depression is a significant problem affecting PwP yet not well treated leading to direct 
medical costs and healthcare costs. On the other hand, common motor symptoms derived 
from bradykinesia, rigidity, and tremors are associated with the physical wellbeing of PwP. 
These symptoms can provoke a fall associated with injury, treatment in hospital, and 
additional social care needs. These factors accelerate a reduction in QoL in PwP.  
Some studies focused on the impact of Parkinson's on wellbeing. Two studies found poorer 
QoL and emotional wellbeing in early onset groups than late-onset of PwP (Knipe et al. 2011; 
Lawson et al. 2014). Another study showed that the subjective wellbeing scores of PwP 
living in a care home were lower than in people living alone in their own home (Cubi-Molla 
and Devlin 2014). Moreover, people with advanced Parkinson's experienced a decline in their 
ability to perform their occupation well due to lower physical, psychological, social and 
spiritual wellbeing leading to the difficulties with their employment. These caused distress 
and disappointment of PwP, as well as impacting on their QoL and wellbeing (Murdock, 
Cousins and Kernohan, 2014). 
 
(B)  Impact on quality of life and wellbeing of carers and family members 
Parkinson's not only impacted on people who are living with the condition, but also affects 
the QoL of caregivers, as assessed using PDQ-carer, questionnaire and Short form (SF)-12 
questionnaire and self-reported wellbeing questions. Studies have found a number of factors 
influencing QoL in carers: age, gender, health status, duration of caregiving role, the level of 
mobility in PwP, and impaired cognitive function in PwP. Most carers were female and were 
the spouse or partner of the PwP. The caregivers mean age ranged 68-72 years. An increase 
in comorbidity, particularly psychiatric symptoms, was found almost five-times higher in 
caregivers compared to the general population of a similar age range. In addition, the QoL of 
caregivers over the long-term duration of caregiving was inferior compared to the general 
population particularly in the four dimensions of social, anxiety and depression, stress, and 
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self-care. Living with PwP had a negative impact on social, psychological, and physical 
wellbeing in carers. It has been reported that Parkinson’s had a widespread impact on 
caregivers’ social, psychosocial, and physical wellbeing (Davey et al. 2004; O’Reilly et al. 
1996; Kudlicka, Clare and Hindle 2014; Peters et al. 2011; Peter et al. 2013; Morley et al. 
2012; Drutyte et al. 2014). Morley et al. (2012) indicated that carer's age, gender, health 
status, caregiving duration, mobility and cognitive impairment were significant factors 
influencing QoL of caregivers.  
Schrag et al. (2004) explored the impact of Parkinson’s on the offspring of PwP. The 
activities of daily living help and the loss in social life were main burdens where the children 
were still in adolescence. In some of adult children, the aspect of caring for their own family 
was a significant influence. Morley et al. (2011) examined the QoL and wellbeing affecting 
younger children and older children of parents with Parkinson’s and multiple sclerosis (MS). 
A comparison found that there was no difference in QoL and wellbeing in either groups. 
Clinical guideline was important for offspring of parental with PD and MS.The NICE 
guidelines for Parkinson’s disease published in 2006, made no reference to the children of 
PWP; many children who were providing informal care to PwP expressed of not having 
enough information about their parent’s Parkinson's (Schrag et al. 2004;  Morley et al. 2011).  
The future guidelines should include adult children for better communication and interaction 
with health professional and PwP condition. 
Falls in PwP were identified as the most important factor that significantly impacted on 
informal care, with carers experiencing anxiety, worry, fear, anger, frustration, and shock due 
to falls in PwP. Increased occurrence of falling in PwP lessened the chances for carers to go 
out for their normal activities, decreased contact with their friends and neighbours. 
Furthermore, falling also increased health care costs of PwP and caregivers (Davey et al. 
2004). Education courses and support for PwP caring role were limited for informal 
caregivers, and they need to be supported by health professionals particularly Parkinson’s 
Disease Specialist Nurse (PDNS).  
The results have been summarised below (Table 4). 
Table 4: UK Studies on Parkinson’s impact on quality of life  
 Theme and Focus Design / Sample Size Reference 
(A)  Impact on QoL - PwP only 
1. Physical and mental functioning, 
independence and self-identity 
Qualitative: 8 in-depth 
interviews of PwP 
BARROW and 
CHARLTON (2002) 
2. Positive impact by participation in 
different daily activities 
Qualitative: 7 in-depth 
interviews of PwP 
BENHAROCH and 
WISEMAN (2004) 
3. QoL differentials: attending 
movement disorder clinic vs. general 
clinic 
Cross-sectional: 42 PwP BLACKWELL, 
BROWN and 
ROCHOW (2005) 
4. QoL and Wellbeing differentials Cross-sectional: 199 PwP CUBI-MOLLA  and 
DEVLIN (2014) 
5. Condition progression (Advanced 
stage) and treatment 
RCT:280 PwP, Sumanirole 
vs. placebo 
DUCHANE and 
JENKINSON (2003) 
6. Non-Motor symptoms at Early stage Epidemiological: 58 PwP and 
99 healthy controls 
DUNCAN et al. 
(2014) 
7. QoL differential factors after Cross-sectional: UK, Italy, FINDLEY et al. 
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controlling for disease severity and 
medication 
Spain, USA, Canada, Japan. 
N=1910 interviews, 203 
clinicians and 1020 PwP 
(2002) 
8. Differentials by young vs older Cross-sectional: 426 PwP KNIPE et al. (2011) 
9. Early stage cognitive impairment Epidemiological: 219 PwP 
and 99 healthy controls 
LAWSON et al. 
(2014) 
10. Differentials by Parkinson’s stages Cross-sectional: 123 PwP LEE et al. (2006) 
11. Differentials and predictors Cross-sectional: 81 PwP LEKWUWA and 
CRAWFORD 
(2014) 
12. Early stage - apathy and impulse 
controls 
Cross-sectional: 99 PwP LEROI et al. (2011) 
13. Parkinson’s progression Qualitative: 10 in-depth 
interviews of PwP 
MURDOCK, 
COUSINS and 
KERNOHAN (2014) 
14. Daily activity - most severe health 
complaints by Parkinson’s progression 
Cross-sectional: 130 PwP POLITIS et al. 
(2010) 
15. Daily activity and management of 
symptoms/complaints by Parkinson’s 
progression 
Cross-sectional: 265 PwP RAHMAN et al. 
(2008) 
16. Motor and Non-Motor symptoms by 
Parkinson’s progression 
Cross-sectional: 162 PwP SHEARER et al. 
(2012) 
17. Wellbeing and social support Cross-sectional: 34 PwP SIMPSON et al. 
(2006) 
(B)  Impact on QoL - Carers and Family members 
1. Fall management by carers Qualitative: 14 in-depth 
interviews of carers  
DAVEY et al. 
(2004) 
2. Stress and financial impact on carers Cross-sectional: 1881 carers DRUTYTE et al. 
(2014) 
3. Stress on carers Cross-sectional: 123 carers SCHRAG et al. 
(2006) 
4. PwP and Carers by Parkinson’s 
severity 
Cross-sectional: 65 PwP, 50 
carers 
KUDLICKA, 
CLARE and 
HINDLE (2014) 
5. PwP and Carers by Parkinson’s 
severity 
Cross-sectional: 238 PwP-
carers 
MORLEY et al. 
(2012) 
6. Health and wellbeing differentials 
Carer spouse vs. non-carer spouse 
Epidemiological: 154 carer 
spouses, 124 non-carer 
spouses as control 
ORIELLY et al. 
(1996) 
7. Health and wellbeing differentials of 
PwP and Carers 
Cross-sectional: 901 PwP, 
734 carers 
PETERS et al. 
(2011) 
8. QoL and health and social services 
experience of Carers of Parkinson's vs. 
Other neurological conditions 
Cross-sectional: 1910 carers 
(434-motor neuron disease, 
721-multiple sclerosis and 
755-Parkinsin’s disease) 
PETERS et al. 
(2013) 
9. QoL of Offspring Cross-sectional: 143 
offspring 
MORLEY et al. 
(2011) 
10. QoL of Offspring Cross-sectional: 89 offspring SCHRAG et al. 
(2004) 
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3.4 Cost of Healthcare Use  
The greatest impact of Parkinson’s is on the deterioration of QoL of both PwPs and 
caregivers. This could also reflect on tremendous economic and financial burden on society 
in terms of social care and health care delivery costs. The overall economic burden of 
Parkinson’s could be assessed through measuring direct medical and non-medical costs, and 
indirect costs.  
The annual total costs of a Parkinson’s case varied markedly between £13,800 (McCrone, 
Allcock and Burn 2007) and £29,000 (Findley et al. 2011). The direct medical costs 
estimated to be £1,881 per patient per annum which comprised of hospitalisation (£1,378), 
professional visits (£385), and test (£117).  Direct non-medical costs (professional care costs) 
were £13,364 per person per annum and indirect costs (informal care costs by families, 
productivity losses, and sick-leave) ranged between £11,000 and £12,500 per person per 
annum (McCrone, Allcock and Burn 2007; Findley et al. 2011). The proportions of direct 
medical costs, direct non-medical costs, indirect costs were 7%, 50% and 43% respectively 
(Findley, et al. 2011). As seen in the previous figure, the overwhelming costs of Parkinson’s 
were direct non-medical costs and indirect costs. In addition, McCrone, Allcock and Burn 
(2007) demonstrated that the burden of informal care cost was the greatest, contributing to 
80.3% of the total costs of £13804, whilst direct social cost was just 5%. Following on the 
studies focusing on the impact on caregivers’ QoL, data showed that most carers were retired, 
female and also the spouse or partner of the PwP. McCrone et al. further argued that as most 
PwP were male, there was underestimation of costs of time put in by female caregivers.  
Total costs of care varied by QoL of PwP in relation to medication cycles and condition 
severity. The severe health states resulted in increasing time spent in OFF state (when 
medication to improve the dopaminergic system and movement was not at its optimal, and 
people experienced tremor, stiffness, slowness of movement, and/or mobility problems), with 
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increasing H&Y scores, and thus resulted in rising costs. Also the longer duration of 
Parkinson’s, depression, gait disturbance, and community/neighbourhood related problems 
resulted in raising the costs further (Findley et al. 2011). Findley (2007) estimated the total 
cost of PD between £450 million and more than £3 billion per year; the underlying variation 
was mainly due to indirect cost and prevalence rate for Parkinson's used in the model. 
The hospitalisation occurrences cost the NHS more as compared to ambulatory care. 
According to hospital admissions data for PwP, 28% were for elective admission and 72% 
non-elective admission as compared to age and sex-matched individuals admitted to hospital 
for who the respective proportions were 60% and 40% (Low et al. 2015). Almost double the 
rate of non-elective admission was found in PwP, with the highest rate (45.3%) recorded in 
those in the age range between 75-84 years (Low, et al. 2015).  The figure of a specific 
excess bed days (EBD) costs was 12% of total costs (Low et al. 2015). Pneumonia, 
Parkinson’s itself, urinary tract infection, cardiac-related and hip fractures were the most 
causes of non-elective admissions. The proportion of falls and fractures particularly hip 
fractures were higher in the total costs (comparison frequencies and costs) (Low et al. 2015). 
These were consistent with motor symptoms in which falls were the significant troublesome 
complaint affecting QoL and informal care costs. Furthermore, PwP who had co-morbidities 
associated with urinary tract infection, pneumonia, hip fractures, were likely to stay longer in 
the hospital, and in those over 85 years, the likelihood of mortality (death) was higher than 
the younger age cohorts (Low et al. 2015). Similarly, Xin et al. (2014) found that pneumonia, 
urinary tract infection, falls and fractures, cardiovascular and circulatory disorders, central 
nervous system and disorders of sense organs, gastrointestinal disorders, and mental disorder 
were the main causes for emergency admissions and hospitalisations in PwP with disease 
progression. 
The PDNS can save expenditure towards doctors and specialist consultations on Parkinson’s 
care. According to Hobson, Roberts and Meara (2003) study the PDNS assessed 321 patients 
and made 881 interventions during one year. The estimated cost saving by employing a 
PDNS was £54,992. Community visits by PDNS potentially saved £8,296 on outpatient and 
£1203 on inpatient visits. Jerman et al. (2002) and Hurwitz et al. (2005) examined PDNS 
intervention and found the nurse specialists had little impact on clinical condition of PwP but 
improved their overall wellbeing without adding to the PwP's healthcare costs.  
A cost-effectiveness and QoL review of Parkinson's undertaken by Dowding, Shenton and 
Salek (2006) found that carers' burden was the major source for economic costs which so far 
had not been factored into cost-effectiveness analyses. The study further stated that 
Parkinson's cost of care including healthcare could significantly be decreased by improving 
HRQoL of carers. The results have been summarised below (Table 5). 
Table 5: UK Studies on healthcare and societal costs related to Parkinson’s 
 Theme and Focus Design / Sample Size Reference 
1.Cost- effectiveness/ QoL 
reviews 
Literature review: 
International 
DOWDING, SHENTON 
and SALEK (2006) 
2. Medication costs differentials 
by Parkinson’s progression 
Cross-sectional: 409 PwP, 
movement disorder clinic 
DODEL et al. (1998) 
3. Economic and healthcare 
impact 
Cross-sectional: 432 PwP FINDLEY et al. (2007) 
4. Healthcare costs: home vs. Cross-sectional: 302 PwP FINDLEY et al. (2011) 
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residential care by severity 
5. Healthcare costs by Parkinson’s 
progression 
Cross-sectional: 444 PwP FINDLEY et al. (2003) 
6. Specialist Nurse service cost Cross-sectional: 321 PwP HOBSON,  ROBERTS, & 
MEARA (2003) 
7. Specialist Nurse Intervention on 
health care costs and QoL 
RCT: 1859 PwP JARMAN et al. (2002); 
HURWITZ et al. (2005) 
8. Hospitalisation costs and 
incidence  
Routine Hospital Episode 
Statistics data for 4 years 
 LOW et al. (2015) 
9. Hospitalisation costs, incidence  
by Parkinson’s progression 
RCT: 2074 PwP, followed 
over 10 years 
XIN et al. (2014) 
10. Healthcare and societal costs 
by severity 
Longitudinal: 174 PwP MCCRONE,  ALLCOCK,  
and BURN (2007) 
11. Societal costs - loss of 
employment 
Quantitative: two datasets: 
151 and 308 PwP 
SCHRAG and BANKS 
(2006) 
12. Employment loss and financial 
burden  
Cross-sectional: 72 PwP CLARKE,  ZOBKIW and 
GULLAKSEN (1995) 
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3.5 Societal Cost of Parkinson’s 
Only a few studies had revealed societal costs of Parkinson's. In terms of (loss of) 
employment in Parkinson’s, the duration since diagnosis of the condition had a direct impact 
on full-time and part-time work in PwP. The more advanced the condition, the less 
employment was noted in those populations. Schrag and Banks (2006) study found that in 
PwP with Parkinson’s duration of more than 5 years, only 6-10% of them were working full-
time and 7% doing part-time jobs. Further, PwP with more than 10 years since diagnosis had 
significantly lower employment rate from the first groups. Additionally, the average time loss 
of employment due to Parkinson’s was 4.9 years. PwP between 5 and 10 years since 
diagnosis stopped working 46% and 82% respectively although gender, type of work, and 
living circumstances had the least influence on average years of employment loss (Schrag 
and Banks 2006). McLaughlin et al. (2011) through in-depth interviews with caregivers had 
outlined the financial implications for providing care to PwP by family members and 
underlined the difficulties in accessing benefits and loss of income.  
Clarke, Zobkiw and Gullaksen (1995) studied the QoL and care of PwP attending movement 
disorders clinic in England and found that the main problems of care was related to 
accommodation, travel, holidays and hobbies.  They also found financial difficulties arose 
amongst PwP due to involuntary early retirement and delay in getting welfare benefits. PwP 
were satisfied with their hospital care, specialised clinic and PDNS input. It was suggested 
that the need was to strengthen the roles of physiotherapists, speech therapists, specialist 
nurses and social workers in the management of Parkinson's, as well as value more carer 
support needs including respite care. Drutyte et al. (2014) found an important stressor 
amongst carers was a reduced household income as due to caring for the PwP, 25% of carers 
had reduced their employment and 30% also experienced a reduction in their financial 
conditions. 
There was a significant correlation between the H&Y score for Parkinson’s and direct 
economic costs of health and social care with the more advanced stage of the condition 
leading to increased direct cost particularly that of social care. These costs by stages varied as 
follows: stage 0 and I, II, III, IV, and V (£2,971, £3,065, £6,183, £10,134, and 18,358 
respectively) (Findley et al. 2003). Those PwP who were in later stages of Parkinson’s were 
likely to become non-responsive to medication (or develop drug resistance) and thus 
aggravate the condition, leading to increased expenditure on health and social care. 
Furthermore, the difference in type of accommodation was a significant variant of the cost of 
care. People who were living in their own home (compared to those in a nursing home) had 
the lowest total of annual direct costs (£4,189). Costs for PwP living full-time in institutional 
care were almost fivefold higher than PwP living in their own home (Findley et al. 2003). 
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2.4 Conclusion 
Parkinson’s is an incurable, long-term, neuro-degenerative condition with movement, 
cognitive, psychological and physiological symptoms that have a substantial impact on QoL, 
especially as the condition progresses particularly as an individual becomes less able to look 
after him or herself. In many cases, Parkinson’s care is informal, as family members and 
friends take on a carer role assisting the PwP. Indeed, the vast majority of the cost of 
managing Parkinson’s has been attributed to informal care and social care, rather than direct 
medical costs. The literature clearly highlights that not only does the QoL of PwP deteriorate 
over time but the QoL of their family members and carers are also severely affected – both in 
economic and social contexts. Family members gave up their time, employment and 
resources, plus watched the deterioration of the QoL of people they cared for; thus 
accentuating the total societal costs. Grey and published literature has also highlighted the 
critical role played by Parkinson's nurses in the management and care of Parkinson's, and 
reiterates that additional funding by the NHS should be allocated for strengthening and 
extending outreach services of Parkinson's nurse specialists (and possibly other health and 
social care specialists) to PwP and their families.  
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Appendix 1: Search Strategy 
Pilot searches in MEDLINE (EBSCO) 
The searches have been written up for MEDLINE using the EBSCO interface and are 
detailed below. 
Explanation of search terms used: ti = title field; ab = abstract field; af = author affiliation 
field; / = controlled vocabulary term; exp. = controlled vocabulary term exploded; asterisk (*) 
= denotes any character; "" = phrase search; n = proximity operator. 
1. parkinson*.ti,ab 
2. parkinsonian disorders/ 
3. parkinson disease/ 
4. or/1-3 
5. cost*.ti,ab 
6. financial.ti,ab 
7. finance*.ti,ab 
8. fiscal.ti,ab 
9. economic*.ti,ab 
10. socio-economic*.ti,ab 
11. wage*.ti,ab 
12. expenditure*.ti,ab 
13. debt*.ti,ab 
14. income*.ti,ab 
15. saving*.ti,ab 
16. employment*.ti,ab 
17. unemployment.ti,ab 
18. pension*.ti,ab 
19. housing.ti,ab 
20. salary.ti,ab 
21. salaries.ti,ab 
22. paid.ti,ab 
23. outlay.ti,ab 
24. outgoings.ti,ab 
25. expense*.ti,ab 
26. price*.ti,ab. 
27. spending.ti,ab 
28. earn*.ti,ab 
29. budget*.ti,ab 
30. payment.ti,ab 
31. burden.ti,ab 
32. sacrifice.ti,ab 
33. deprive*.ti,ab 
34. "quality of life".ti,ab 
35. carer* N3 health.ti,ab 
36. carer* N3 impact.ti,ab 
37. carer* N3 "well being".ti,ab 
38. carer* N3 wellbeing.ti,ab 
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39. carer* N3 "quality of life".ti,ab 
40. family N3 health.ti,ab 
41. family N3 impact.ti,ab 
42. family* N3 wellbeing.ti,ab 
43. family* N3 "well being".ti,ab 
44. family* N3 "quality of life".ti,ab 
45. families N3 health.ti,ab 
46. families N3 impact.ti,ab 
47. families N3 "well being".ti,ab 
48. families N3 wellbeing.ti,ab 
49. families N3 "quality of life".ti,ab 
50. caregiver* N3 health.ti,ab 
51. caregiver* N3 impact.ti,ab 
52. caregiver* N3 wellbeing.ti,ab 
53. caregiver* N3 "well being".ti,ab 
54. caregiver* N3 "quality of life".ti,ab 
55. cost of illness/ 
56. costs and cost analysis/ 
57. health care costs/ 
58. health expenditures/ 
59. direct service costs/ 
60. hospital costs/ 
61. drug costs/ 
62. cost savings/ 
63. financial support/ 
64. financial management, hospital/ 
65. financial management/ 
66. economics/ 
67. models, economic/ 
68. economics, hospital/ 
69. socioeconomic factors/ 
70. salaries and fringe benefits/ 
71. employment/ 
72. health expenditures/ 
73. income/ 
74. pensions/ 
75. housing/ 
76. quality of life/ 
77. or/5-76 
78. "united kingdom".af 
79. uk.af 
80. britain.af 
81. scotland.af 
82. england.af 
83. wales.af 
84. "northern ireland".af 
85. exp. great britain/ 
86. england/ 
87. northern ireland/ 
88. exp. scotland/ 
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89. wales/ 
90. channel islands/ 
91. guernsey/ 
92. or/78-91 
93. 4 and 77 and 92  
94.  
 
Grey literature searches 
 
NICE Evidence Search = 1015 results 
 
((parkinson*) AND (cost* OR financ* OR economic* OR expenditure* OR debt* OR income* OR 
pension* OR salar* OR spending OR earn* OR budget* OR burden OR sacrifice OR "quality of life" 
OR carer OR famil* OR caregiver)) 
 
This search was shortened as the number of characters allowed was limited. The results were also 
limited to anything published in the last three years. 
 
Google.co.uk = 36,700,000 results 
 
((parkinson*) AND (cost* OR financ* OR economic* OR expenditure* OR debt* OR income* OR 
pension* OR salar* OR spending OR earn* OR budget* OR burden OR sacrifice OR "quality of life" 
OR carer OR famil* OR caregiver)) 
 
This search was shortened as the number of characters allowed was limited. 
 
 
